Improvement was significantly greater with BDP nasal aerosol (80 mg/day) than with placebo over the first 6 wk of treatment in children 6-11 y of age in average am and pm rTNSS and iTNSS (mean [95% CI] treatment difference: -0.66 [-1.08, -0.24], P = 0.002 and -0.58 [-0.99, -0.18], P = 0.004, respectively).